Innovation is America’s backbone.

It creates jobs here and improves lives everywhere.

Let’s protect it.

Watch our Latest Video

Patents Save Lives

From diagnostics to therapeutics and vaccines, patent rights underpin the innovations responsible for saving millions of lives during the Covid-19 pandemic and beyond.

IP Fosters Economic Growth

IP-intensive sectors, from film and music to high-tech manufacturing and life sciences, employ 45 million Americans and account for over one-third of total U.S. GDP.

IP Rights Tackle Global Challenges

Strong patent rights facilitate pioneering discoveries that are fit to address today's energy security, climate change, and public health concerns.

IP Rights Drive High-Value Creative Industries

Strong IP rights, from copyrights to trademarks, incentivize the development of creative works that fuel the economy and benefit the general public.

Predictable and high-quality intellectual property rights have propelled America’s innovative leadership ever since they were enshrined in the Constitution.

Bill Is Key To Protecting US Economy From Patent Piracy

Stories of IP in Action

Blog

C4IP Coalition Updates: September 2024

September was a productive month for C4IP! Here’s a roundup of all that we accomplished over the past month. September Highlights: Advancing the Patent Eligibility Restoration Act The Patent Eligibility Restoration Act (PERA) remains one of the most important innovation ...
Blog

This Month in IP: September 2024

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From clothing to cleaning, every aspect of our lives has benefited greatly from IP, as shown by these historical examples ...
Blog

Fact Check: The Medication Affordability and Patent Integrity Act Would Unnecessarily Overhaul a Well-Functioning Patent System

The Medication Affordability and Patent Integrity Act, introduced by Senators Maggie Hassan (D-NH) and Mike Braun (R-IN), would require life sciences innovators to share volumes of unnecessary and confidential information related to drug approval with the USPTO. Under the bill, ...
Scroll to Top